Weeks after a federal judge issued a lifetime ban forbidding Martin Shkreli's participation in the pharmaceutical industry, the disgraced so-called "Pharma Bro" and his old companies reached a $28 million deal that would resolve his litigation with Blue Cross and Blue Shield.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
